Christopher J. Kirk Kezar Life Sciences, Inc. (KZR) insider trading activity

KZR Quotes by TradingView

Christopher J. Kirk is CEO of Kezar Life Sciences, Inc.. Currently has a direct ownership of 431,348 shares of KZR, which is worth approximately $237,241. The most recent transaction as insider was on Jul 20, 2023, when has been sold 48,950 shares (Common Stock) at a price of $0.9 per share, resulting in proceeds of $44,055. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 431K
0% 3M change
13.07% 12M change
Total Value Held $237,241

Christopher J. Kirk Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 20 2023
BUY
Exercise of conversion of derivative security
$44,055 $0.9 p/Share
48,950 Added 10.19%
431,348 Common Stock
Jun 23 2022
BUY
Exercise of conversion of derivative security
$29,754 $0.9 p/Share
33,060 Added 7.98%
381,484 Common Stock
CJK

Christopher J. Kirk

CEO
South San Francisco, CA

Track Institutional and Insider Activities on KZR

Follow Kezar Life Sciences, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KZR shares.

Notify only if

Insider Trading

Get notified when an Kezar Life Sciences, Inc. insider buys or sells KZR shares.

Notify only if

News

Receive news related to Kezar Life Sciences, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on KZR